PGT / Genetic Testing in DLF Phase 3: A Complete Guide for Gurgaon Families

Preimplantation Genetic Testing is a laboratory procedure performed on embryos created through IVF before they are transferred to the uterus. For families in DLF Phase 3, where a large proportion of residents are educated professionals making informed, research-driven healthcare decisions, PGT represents the intersection of reproductive science and personal responsibility.

PGT-A (formerly PGS) screens all 24 chromosomes to identify embryos that are euploid — meaning they carry the correct number of chromosomes. Aneuploid embryos, which carry extra or missing chromosomes, are the leading cause of implantation failure and early miscarriage. By selecting only chromosomally normal embryos for transfer, couples significantly reduce the risk of failed cycles and pregnancy loss.

PGT-M (formerly PGD) goes a step further by testing for specific inherited single-gene disorders. This is particularly relevant for DLF Phase 3 families with a known family history of conditions such as thalassaemia — prevalent in certain Indian communities — or neurological conditions like spinal muscular atrophy. Reviewed by the HomeIVF Medical Board, this form of testing requires prior genetic counselling to map the specific mutation in question before the IVF cycle begins.

Together, PGT-A and PGT-M give couples the best available scientific foundation for a healthy pregnancy.

Understanding the PGT process helps DLF Phase 3 residents plan both their time and expectations. Here is a clinically accurate overview of each stage.

Step 1 — Initial Consultation and Genetic Counselling: A HomeIVF fertility specialist (part of the HomeIVF Medical Board network) meets with the couple — via video or at home — to review medical history, determine the appropriate PGT type, and recommend genetic counselling where required for PGT-M cases.

Step 2 — Ovarian Stimulation: The female partner undergoes a controlled ovarian stimulation (COS) protocol using injectable gonadotropins, typically over 10–14 days. Monitoring via ultrasound and hormone tests tracks follicle development.

Step 3 — Egg Retrieval and Fertilisation: Mature eggs are retrieved under sedation and fertilised using ICSI (intracytoplasmic sperm injection) to maximise fertilisation rates, which typically range from 70–80%.

Step 4 — Embryo Biopsy: On Day 5 or Day 6 of embryo development (blastocyst stage), an embryologist performs a trophectoderm biopsy — removing 5–8 cells from the outer layer of the embryo. The embryos are then vitrified (frozen) while awaiting results.

Step 5 — Genetic Analysis: Biopsied cells are sent to an accredited genetics laboratory. Results are available in 10–14 business days.

Step 6 — Frozen Embryo Transfer (FET): A euploid embryo is selected and transferred in a subsequent prepared cycle, with ongoing luteal phase support.

HomeIVF coordinates all these steps with minimal disruption to your professional schedule in DLF Phase 3.

Not every IVF patient requires PGT, but several clinical scenarios make it strongly advisable. The HomeIVF Medical Board recommends considering PGT-A under the following circumstances:

Advanced Maternal Age (AMA): Women aged 35 and above have a significantly higher rate of chromosomal abnormalities in eggs. By the age of 40, studies indicate that more than half of all embryos may be aneuploid. PGT-A helps isolate the viable minority for transfer.

Recurrent Implantation Failure (RIF): Couples who have undergone two or more failed embryo transfers despite good-quality embryos are strong candidates for PGT-A, as undetected aneuploidy is a leading unexplained cause.

Recurrent Pregnancy Loss (RPL): Couples with two or more clinical miscarriages benefit from PGT-A to rule out chromosomal causes, which account for up to 60% of first-trimester losses.

Severe Male Factor Infertility: High rates of sperm DNA fragmentation are associated with increased embryo aneuploidy, making PGT-A a valuable safety net.

PGT-M is specifically indicated when one or both partners carry a known genetic mutation — such as thalassaemia trait, a common finding in certain communities well-represented in Gurgaon — or when a previous child has been born with a heritable genetic condition. Carrier screening can be arranged by HomeIVF prior to the IVF cycle for DLF Phase 3 families who are unsure of their carrier status.

When DLF Phase 3 residents compare HomeIVF against conventional fertility clinics in Gurgaon, several structural differences stand out beyond the obvious convenience of at-home care.

Typical IVF clinics in Gurgaon require patients to visit the clinic for every monitoring scan, consultation, injection training, and review appointment — often multiple times per week during stimulation. For residents of DLF Phase 3 navigating peak-hour traffic toward Sector 29, MG Road, or Sohna Road clinic corridors, this translates to hours of lost productivity per cycle.

HomeIVF's coordinated model includes home visits for hormone monitoring, nurse-assisted injection training at your residence, teleconsultation follow-ups, and a dedicated care coordinator who manages your entire treatment calendar. Genetic counselling is integrated into the cycle, not billed separately as it often is at standalone clinics.

The HomeIVF package — starting from ₹1.5 lakh — bundles consultation, stimulation monitoring support, coordination with accredited lab partners for PGT biopsy and analysis, and post-transfer luteal support into a transparent, pre-disclosed cost structure. This contrasts with the fragmented billing that many Gurgaon clinic patients report, where add-ons like ICSI, embryo freezing, and genetic testing are priced separately after the initial quote. The HomeIVF Medical Board reviews all clinical protocols to ensure they align with ICMR guidelines and international best practices.

DLF Phase 3 is one of Gurgaon's most privacy-conscious residential zones. The community of senior executives, entrepreneurs, and dual-income professional couples living in its upscale villas and gated societies places a premium on discretion, time, and personalised service — values that align directly with HomeIVF's operating model.

Privacy: Fertility treatment remains a sensitive topic in many Indian families. Visiting a well-known fertility clinic in a busy Gurgaon commercial hub can feel exposing. HomeIVF brings clinical-grade care directly to your home, maintaining the confidentiality that DLF Phase 3 residents expect.

Time Efficiency: A typical IVF monitoring cycle requires 6–8 clinic visits over two weeks. For a senior professional at an MNC with offices near Cyber Hub — a five-minute drive from DLF Phase 3 — every midday clinic appointment represents a professional cost. HomeIVF schedules home visits around your calendar, including early morning and evening slots.

Senior Specialist Access: HomeIVF's network includes experienced reproductive medicine specialists and embryologists affiliated with accredited laboratories. Patients in DLF Phase 3 are assigned a consistent care team rather than rotating junior doctors at walk-in clinics.

Emotional Comfort: IVF is emotionally demanding. Being monitored and counselled in your own home environment has documented benefits for patient wellbeing and treatment compliance, both of which influence cycle outcomes.

DLF Phase 3 occupies a strategically connected part of Gurgaon, bordered by Golf Course Road to the east and within easy reach of NH-48. Its proximity to Cyber Hub and Cyber City means that most residents are already embedded in a high-digital-literacy environment — accustomed to app-based healthcare, teleconsultations, and on-demand services. HomeIVF's platform fits naturally into this lifestyle.

For procedures that require in-person clinical attendance — specifically the egg retrieval and embryo transfer, which are performed under sedation at an accredited facility — HomeIVF partners with NABH-accredited procedure centres within a short, pre-planned commute from DLF Phase 3. Your care coordinator maps the logistics in advance so there are no day-of surprises.

The DLF Phase 3 area also has access to several diagnostic labs and pharmacies along MG Road and Sector 29 that stock fertility medications prescribed during the stimulation phase. HomeIVF's pharmacy coordination service can arrange home delivery of injectable medications in temperature-controlled packaging, removing yet another logistical burden.

For couples who have relocated from other Indian cities or abroad for work assignments near Cyber City, HomeIVF's digital-first model also accommodates pre-move consultations, meaning your fertility plan can be active before you even settle into your DLF Phase 3 home.

Fertility treatment costs, including PGT, are a significant consideration for most families. While Indian health insurance policies have historically excluded IVF and genetic testing, the landscape is beginning to shift. Some group health insurance plans offered by MNCs — common employers for DLF Phase 3 residents — are starting to include partial fertility benefits. Residents are advised to check their HR policy documents or contact their insurer directly.

HomeIVF's finance team assists patients in reviewing their policy documents and identifying any applicable reimbursable components, such as diagnostic investigations, hormonal blood tests, or ultrasound monitoring, which may fall within existing policy coverage even when the IVF cycle itself does not.

For the remaining out-of-pocket expense, HomeIVF has partnerships with leading healthcare financing platforms that offer no-cost EMI options with tenures ranging from 6 to 24 months, subject to eligibility. This allows DLF Phase 3 families to manage treatment costs without drawing down savings or delaying care.

The HomeIVF Medical Board also recommends that couples begin financial planning 3–6 months before initiating an IVF cycle, as multiple cycles may be required to achieve a successful pregnancy. IVF success rates in India typically range from 40–55% per cycle depending on age and cause, and PGT-A significantly improves per-transfer success by eliminating aneuploid embryos from the candidate pool.

Beginning your fertility journey with HomeIVF from DLF Phase 3 is designed to be as simple and low-friction as possible. Here is exactly how to get started.

Step 1 — Book a Free Discovery Consultation: Use the HomeIVF website or app to schedule a free 30-minute teleconsultation with a fertility advisor. You can select slots that fit around your Cyber Hub or Cyber City work schedule, including early morning and late evening options.

Step 2 — Initial Medical Review: A HomeIVF Medical Board-affiliated specialist reviews your medical history, previous investigations, and reproductive goals. If you have existing reports — semen analysis, AMH, antral follicle count ultrasound — upload them directly to your HomeIVF digital patient file.

Step 3 — Personalised Treatment Plan: Within 48 hours, you receive a written treatment plan specifying whether PGT-A, PGT-M, or both are recommended, along with a clear cycle timeline and cost disclosure.

Step 4 — Cycle Kickoff: A HomeIVF nurse coordinator visits your DLF Phase 3 home to conduct baseline investigations, provide injection training, and establish your monitoring schedule. Your IVF cycle begins.

Step 5 — Ongoing Support: Throughout stimulation, retrieval, PGT, and transfer, your dedicated HomeIVF care team remains accessible via app, WhatsApp, and phone — ensuring that DLF Phase 3 families never feel alone in the process.

The HomeIVF platform is built for the professional families of DLF Phase 3: intelligent, busy, and deserving of the best reproductive medicine India has to offer.